Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: April 2020

4/30/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 71% of Russian Doctors Report Serious Problems with Providing Healthcare Facilities with Personal Protective Equipment (PPE)

Only 8% of Russian doctors say that the healthcare facilities they work in provide all the necessary personal protective equipment, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 17% say that there have been some interruptions in the provision, but the situation is not critical in general.

4/30/2020 Database Update: Pharmaceutical Drug Production in Russia (March and Q1 2020)

Between January and March 2020, Russia manufactured 102.6 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 18 higher than that of the same period in 2019. While the dynamics in monetary terms are promising and not much different from those in late 2019, the dynamics in physical terms (units) are only +0.2%, with 1 bln units manufactured. If calculated in minimum dosage units (MDU), the manufactures volume amounts to 18.6 bln MDUs, with the dynamics of +8.2%.

4/28/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (March and Q1 2020)

In Q1 2020, the sales of veterinary drugs in the retail market amounted to 4.88 bln RUB (retail prices, VAT included), with the dynamics of +20.4%. The high dynamics could be explained by a number of factors, in particular average price increase and increased demand. The latter could be attributed to atypical weather earlier this year, hence a shift in demand. If calculated in minimum dosage units (MDU), the market volume is 47.4 bln MDUs, with the dynamics of more than +10%.

4/27/2020 Veterinary Vaccine Import to Russia (Q1 2020)

Between January and March 2020, Russia imported 2.1 bln RUB worth of veterinary vaccines (customs clearance prices), which is in monetary terms (rubles) 8.4% lower than that of the same period in 2019. The dynamics in physical terms (units) are as low as -24.8%, or, if calculated in dosages, 13.5%. The import volume amounts to 1.13 mln units, or around 10.16 bln dosages.

4/27/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Pharmacists Will not Start Online Sales Even after Official Permission

33% of pharmacists say that they consider online drug sales to be unethical, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 20% noted that they simply would not be able to compete with large online retailers, which makes online development pointless.

4/21/2020 Database Update: Pharmaceutical Drug Import to Russia (March and Q1 2020)

Between January and March 2020, Russia imported 60.4 bln RUB worth of ready-made pharmaceuticals (customs clearance prices, VAT included), which is in monetary terms (rubles) 52% lower than that of the same period in 2019. Russia is still using the volumes imported to Russia last year as part of the preparation for the introduction of the labeling system. However, the dynamics of the in-bulk import are +10%, with the volume of 33.1 bln RUB.

4/3/2020 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (February 2020)

Between January and February 2020, Russia imported 2.46 bln RUB worth of veterinary drugs (customs clearance prices), which is monetary terms (rubles) 37% lower than that of the same period in 2019. The import volume of feed supplements amounted to 4.35 bln RUB, with the dynamics of -20%. As for veterinary APIs, the import volume is 306 mln RUB, and the dynamics are -14%.

4/2/2020 Database Update: API Import to Russia (February 2020)

Between January and February 2020, Russia imported 22.6 bln RUB worth of APIs (customs clearance prices, VAT included), which is in monetary terms (rubles) 18.5% higher than that of the same period in 2019. The dynamics in physical terms are +31%, with 2.2 thousand tons of APIs.

4/1/2020 Database Update: Pharmaceutical Drug Import to Russia (February 2020)

Between January and February 2020, Russia imported 27 bln RUB worth of ready-made pharmaceuticals (customs clearance prices), which is in monetary terms (rubles) 65% lower than that of the same period in 2019. The import volume of the first two months of 2020 turned out to be lower than that of any January, when the activity of the importers is usually the lowest. The dynamics of the in-bulk import in monetary terms are +28%, with the volume of 22.5 bln RUB.